Search
Tevogen Bio Holdings Inc
TVGNAdd to Watchlist
6.690USD
-0.030-0.45%
Close 07-31 16:00（ET）Quotes delayed by 15 min
537.98KMarket Cap
LossP/E TTM
More Details of Tevogen Bio Holdings Inc Company
Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company. The Company is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489, has developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic lingering symptoms of the disease. Its TVGN 601 is being developed for multiple sclerosis (MS), and its TVGN 930 is being developed for EBV-associated lymphomas.
Tevogen Bio Holdings Inc Info
Ticker SymbolTVGN
Company nameTevogen Bio Holdings Inc
IPO dateNov 04, 2021
CEOSaadi (Ryan)
Number of employees18
Security typeOrdinary Share
Fiscal year-endNov 04
Address15 Independence Boulevard, Suite #210
CityWARREN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code07059
Phone16468078832
Websitehttps://tevogen.com/
Ticker SymbolTVGN
IPO dateNov 04, 2021
CEOSaadi (Ryan)
Company Executives of Tevogen Bio Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Kirti Desai
Mr. Kirti Desai
Chief Financial Officer
Chief Financial Officer
242.98K
+16.46%
Dr. Neal Flomenberg, M.D.
Dr. Neal Flomenberg, M.D.
Chief Scientific Officer and Global R&D Lead
Chief Scientific Officer and Global R&D Lead
74.52K
+3.25%
Mr. Jeffrey Feike
Mr. Jeffrey Feike
Independent Director
Independent Director
54.03K
+74.03%
Dr. Keow Lin (Lindee) Goh
Dr. Keow Lin (Lindee) Goh
Independent Director
Independent Director
46.28K
+86.43%
Ms. Susan M. Podlogar
Ms. Susan M. Podlogar
Independent Director
Independent Director
46.28K
+86.43%
Mr. Sadiq Khan
Mr. Sadiq Khan
Chief Commercial Officer
Chief Commercial Officer
4.00K
--
Dr. Ryan Saadi, M.D.
Dr. Ryan Saadi, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Curtis Patton
Dr. Curtis Patton
Independent Director
Independent Director
--
--
Mr. Victor Sordillo
Mr. Victor Sordillo
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Kirti Desai
Mr. Kirti Desai
Chief Financial Officer
Chief Financial Officer
242.98K
+16.46%
Dr. Neal Flomenberg, M.D.
Dr. Neal Flomenberg, M.D.
Chief Scientific Officer and Global R&D Lead
Chief Scientific Officer and Global R&D Lead
74.52K
+3.25%
Mr. Jeffrey Feike
Mr. Jeffrey Feike
Independent Director
Independent Director
54.03K
+74.03%
Dr. Keow Lin (Lindee) Goh
Dr. Keow Lin (Lindee) Goh
Independent Director
Independent Director
46.28K
+86.43%
Ms. Susan M. Podlogar
Ms. Susan M. Podlogar
Independent Director
Independent Director
46.28K
+86.43%
Mr. Sadiq Khan
Mr. Sadiq Khan
Chief Commercial Officer
Chief Commercial Officer
4.00K
--
FAQs
Who are the top five shareholders of Tevogen Bio Holdings Inc?
The top five shareholders of Tevogen Bio Holdings Inc are: Mr. Kirti Desai
How many institutions hold shares of Tevogen Bio Holdings Inc (TVGN)?
As of 2026Q1, 115 institutions hold shares of Tevogen Bio Holdings Inc, with a combined market value of approximately 168.15K, accounting for 4.02% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -44192.00.